Evidence map›Paper›PMID 41010120›Full record

ArticleMaterials (Basel, Switzerland)2025

Innovative Application of Standard Sand as a Functional Carrier for Nano-Silica in Cement.

Meytal Shalit, Yaniv Knop, Maya Radune, Yitzhak Mastai

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meytal ShalitDepartment of Chemistry, The Institute of Nanotechnology, Bar-Ilan University, Ramat Gan 52900, Israel.ORCID 0000-0002-9718-5245
Yaniv KnopDepartment of Civil Engineering, Ariel University, Ariel 40700, Israel.
Maya RaduneDepartment of Civil Engineering, Ariel University, Ariel 40700, Israel.
Yitzhak MastaiDepartment of Chemistry, The Institute of Nanotechnology, Bar-Ilan University, Ramat Gan 52900, Israel.ORCID 0000-0002-7330-0886

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nano-silica (NS) is used to enhance the mechanical and durability properties of cementitious materials; however, its frequent tendency to agglomerate limits its effectiveness and uniform distribution within the cement matrix. The main goal of this study was to improve NS dispersion and therefore to improve the properties of the concrete by coating NS onto standard sand particles (sand@NS) using the Stöber method, creating a composite material that acts as a filler, nucleation site, and highly reactive pozzolanic agent. The resulting sand@NS was incorporated into cement mixtures, and its compressive strength was measured after 3, 7, and 28 days of curing. In addition, water absorption and microstructural density were also evaluated. Comparative results showed that sand@NS significantly enhanced early-age hydration and initial strength, with a 145% increase in compressive strength at 28 days compared to the reference, whereas free NS resulted in a 120% increase. The early-age strength improvement was mainly due to the increased number of nucleation centers, while later strength gains were attributed to pozzolanic activity of the immobilized NS. Additionally, sand@NS reduced water absorption and increased microstructural density, even with reduced cement content, supporting more sustainable and eco-efficient concrete production. This work shows a promising, scalable, and cost-effective strategy to maximize the performance of NS in cementitious systems and supports its broader adoption in advanced construction materials.

Indexed as

calcium silicate hydrate (CSH)compressive strengthnanomaterialsNano-SiO2pozzolanssand

Identifiers

PMID41010120
PMCPMC12471318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.